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Abstract
Background Long-term data of health-related quality of life
(HRQL) after biliopancreatic diversion with duodenal switch
(BPDDS) procedure are lacking. The aim of this study was to
evaluate changes in HRQL from baseline to 5 years after
BPDDS.
Methods Fifty morbidly obese patients were followed for
5 years after BPDDS procedure. The sample consisted of 27
women and 23 men, the mean age was 37.8 years, and the
mean body mass index (BMI) was 51.7 units. HRQL was
measured with the Short Form 36 questionnaire (SF-36).
Anxiety and depression were measured with the Hospital
Anxiety and Depression Scale (HADS). Linear mixed model
was used to investigate the change scores. The SF-36 scores
and HADS scores of the sample were also compared with a
Norwegian population norm, adjusted for age, gender, and
BMI.
Results Mental summary scores (MCS) and physical summary
scores (PCS) were very low preoperatively but significantly
improved (P<0.05) 5 years after surgery. The PCS was
comparable to the population norm, while MCS was lower.
Depression improved significantly from baseline to the 5-year
follow-up (P=0.004), but anxiety did not (P=0.595).
Conclusions This study demonstrates a sustained weight loss
and improved, although somewhat fading, HRQL scores
5 years after BPDDS. The study also shows that BPDDS is
associated with a sustained reduction in depression symptoms
but not in anxiety symptoms.
Keywords Obesity . Obesity surgery . Quality of life .
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Introduction
Morbid obesity is associated with a range of serious health
complications and reduced health-related quality of life
(HRQL) [1], and patients suffering from morbid obesity also
have an increased risk for symptoms of anxiety and depression
[2]. The only treatment documented to provide sustained weight
loss in patients with morbid obesity is bariatric surgery [3–7].
Improvement in HRQL is the main objective of surgical
treatment in morbid obesity [8]. Several studies have shown
that morbidly obese patients experience a dramatic improve-
ment in HRQL after surgery [9–15]. Although surgery may
lead to a significant relief from anxiety and depression [16],
the improvements may wane with time [9, 17].
There are several surgical procedures for weight loss, such
as gastric bypass, gastric banding, sleeve gastrectomy, and
biliopancreatic diversion without (BPD) or with the duodenal
switch (BPDDS) [18]. BPDDS seems to be the most effective
surgical procedure for weight loss and weight loss mainte-
nance [3, 19, 20], but there are little long-term data (≥5 years)
on HRQL after BPDDS. Only one cross-sectional study has
shown that severely obese patients who underwent BPDDS
had better HRQL than a group of patients prior to receiving
BPDDS surgery [21].
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The main aim of this study was to evaluate changes in
HRQL from baseline to 5 years after BPDDS. The primary
outcomes were the two summary scores of the Short Form 36:
the physical component score (PCS) and the mental compo-
nent score (MCS). We hypothesized that significant improve-
ments would occur in both these measurements of HRQL.
Methods
Study Design and Patients
Our bariatric surgery program was initiated in 2001, and the
first 51 patients who were accepted for BPDDS were invited
to participate in the present study. The inclusion criteria were
body mass index (BMI)≥40.0 or 35.0–39.9 with obesity-
related comorbidities, age 18–60 years, no alcohol or drug
problems, no active psychosis, and failure to lose weight
through other methods. Patients were assessed before surgery
and 1, 2, and 5 years after surgery by self-reported
questionnaires.
Power calculations were performed using a two-sided
paired test (predicted effect size (ES)=0.6, providing 90 %
power, P<0.05), indicating that at least 32 paired observations
would be required to detect changes in the health-related
quality of life scores. To ensure that the study was robust
concerning missing data, 51 patients were recruited.
The Treatment: Biliopancreatic Diversion with Duodenal
Switch
BPDDSwas performed by resecting the greater curvature of the
stomach, leaving a narrow gastric tube of 100 to 200 ml along
the lesser curvature. The pylorus was left intact, and the duo-
denum was divided 3 to 4 cm distal to the pylorus. The small
bowel was divided 200–300 cm above the cecum, and the
proximal end of the distal small bowel was anastomosed to
the proximal end of the duodenum (alimentary limb). The distal
end of the proximal small bowel was anastomosed to the
alimentary limb 50 to 100 cm above the cecum (common limb).
Patients were encouraged to have protein-rich foods after the
procedure and to take prescribed daily doses of vitamins and
minerals [22].
Demographic Characteristics and Clinical Data
Data were obtained using a standardized form. The patients’
age, gender, educational level, employment status, marital
status, and BMI were noted. Body weight was measured in
light clothing without shoes to the nearest 0.1 kg. Height
was measured in standing position without shoes to the
nearest 0.01 m. BMI was calculated as weight divided by
height squared (kg/m2). Percent excess body mass index
loss (%EBMIL) from baseline to the 5-year follow-up was
calculated using the following formula: 100−(Follow-up
BMI−25 / Beginning BMI−25)×100) [23].
Outcome Variables
Medical Outcomes Study Short Form 36
The Short Form 36 (SF-36; Norwegian version 1.2) is a well-
established generic measure of the health burden of chronic
diseases [24]. The questionnaire has demonstrated good va-
lidity and reliability [25]. SF-36 assesses eight dimensions of
physical and mental health, each ranging from 100 (optimal)
to 0 (poorest). The subscales of physical functioning, physical
role function, and bodily pain reflect physical health, and
emotional role function and mental health reflect mental
health status. The subscales of general health, vitality, and
social functioning reflect both physical and mental health.
The eight SF-36 subscales can also be factor-analyzed and
reduced to two summary scores, PCS and MCS [24]. To
calculate the PCS and MCS, we used the oblique method
which allows for the correlation of physical and mental health
[26]. A higher score on either scale represents better physical
or mental health. Respectively, PCS and MCS are standard-
ized so that a difference in 2–4.9 points can be interpreted as a
small effect size; 5–7.9 points, a medium effect size; and
8+ points, a large effect size [26, 27]. Normative data on the
SF-36 was obtained from the Norwegian survey in 2002
(N=5,396) [28].
Hospital Anxiety and Depression Scale
To evaluate symptoms of anxiety and depression, patients
were administrated the Hospital Anxiety and Depression
Scale (HADS), a self-reported questionnaire. HADS is com-
posed of 14 items, with 7 items assessing anxiety and 7 items
assessing depression. The item scores for anxiety and depres-
sion were added separately and given subscale scores, each
ranging from 0 to 21. A score >10 on either subscale indicates
a probable case of mood disorder, a score of 8–10 indicates a
possible case, and a score <8 is within normal range [29]. The
HADS has shown good case-finding properties in primary
care and hospital settings for anxiety and depression according
to the Diagnostic and Statistical Manual of Mental Disorders
and International Classification of Diseases [30]. The HADS
is well suited for detecting mood disorders among obese
people and has shown good responsiveness to change in
patients operated for morbid obesity [9]. Effect sized for the
HADS scores can be interpreted according to standard devia-
tion units from the norm population. Thus, a difference in
HADS–anxiety (HADSA) of 0.7 to 1.6 points can be
interpreted as a small effect size; 1.7 to 2.6 points, a medium
effect size; and 2.7+ points, a large effect size [27]. Similarly, a
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difference in HADS–depression (HADSD) of 0.6 to 1.6 points
can be interpreted as a small effect size; 1.7 to 2.5 points, a
medium effect size; and 2.5+ points, a large effect size.
Normative data on the HADS were obtained from the Nord-
Trøndelag Health Study in Norway (1994–1996) [31, 32].
Statistical Analysis
To estimate changes over time, we used a linear mixed
model. Time was included in the model as a categorical
variable, whereas the intraindividual correlation was
modeled using an unstructured variance–covariance matrix.
Changes from the pre-surgery state to the 5-year follow-up are
the main analysis of this study. We also report P values for
changes from the highest score by the 1 or 2-year follow-up
to the 5-year follow-up. Pearson’s r was used to study
the correlation between change in BMI units and change
in HRQL.
Normative scores for the SF-36 and HADS for the 5-year
follow-up were adjusted for (1) age and gender and then for
(2) age, gender, and BMI to reflect the same distributions as
that of our sample. Analysis of covariance (ANCOVA) was
used to calculate normative scores for the SF-36. The cal-
culation of normative HADS scores was based on published
results [31, 32], and the method for this is described else-
where [33]. ANCOVA (SF-36) and the one-sample test
(HADS) were used to compare the patients’ scores after
5 years with the normative scores (both unadjusted and ad-
justed for BMI). Statistical analysis was performed with SPSS
for Windows version 20.0. P values<0.05 were considered
statistically significant.
Ethics
The investigation conforms to the principles outlined in the
Declaration of Helsinki. The study was approved by The
Norwegian Social Science Data Services and by the
Regional Committee of Ethics in Medicine, West Norway.
Results
All 51 patients (28 women and 23 men) who were invited
gave their written informed consent. At the time of surgery,
the mean age was 37.8±8.1 years and mean BMI=51.7
units (SD 7.5). One patient died after 2 years and was
excluded from the study. Forty-six patients (92 %) complet-
ed the SF-36 questionnaire and 44 patients (88 %) complet-
ed the HADS questionnaire 5 years after surgery.
We had complete data on all patients for change in BMI,
and the mean BMI at 5 years was 32.9±6.6 units (P<0.001
from baseline) and was stable over time (Fig. 1). The aver-
age %EBMIL at 5 years was 70.1±24.0.
PCS improved from baseline to the five5-year follow-up
(P<0.001, ES=1.58; Table 1, Fig. 2), but a significant decline
was observed between 2 and 5 years (P=0.001). The effect
size for PCS compared to the norm population adjusted for
age, gender, and BMI was small after 5 years (P=0.135).
MCS also improved significantly from baseline to the 5-
year follow-up (P=0.003, ES=0.77; Table 1, Fig. 2), but a
decline was observed between 1 and 5 years (P<0.001). The
effect size for MCS compared to the norm population adjusted
for age, gender, and BMI was moderate at 5 years (P<0.001).
The HADSA did not significantly improve from baseline
to the 5-year follow-up (P=0.139, ES=0.29). This was due
to a significant decline between the 2- and 5-year follow-up
(P=0.003; Table 1, Fig. 3). The effect size for anxiety
compared to the normative population adjusted for age,
gender, and BMI was moderate at 5 years (P<0.001).
The HADSD score improved significantly from baseline
to the 5-year follow-up (P=0.001, ES=0.8), but it declined
significantly between 2 and 5 years (P=0.004; Table 1,
Fig. 3). The effect sizes for HADSD compared to the nor-
mative population adjusted for age, gender, and BMI indi-
cated no important difference at 5 years (P=1).
Of all the HRQL measures, only changes in physical
functioning at the 5-year follow-up were significantly cor-
related with weight loss (r=0.45, P=0.005).
Discussion
This is, to our knowledge, the first study that prospectively
evaluated long-term changes in HRQL after BPDDS.
Although Marceau et al. [21] also showed good long-term
results for HRQL after BPDDS, their results were cross-
sectional. Despite small early declines in HRQL scores
(from 1 and 2 years), they remained significantly higher both
statistically and clinically as to baseline at the 5-year follow-
up. The HADSD score, not the HADSA score, showed large
and sustained improvements after surgery.
Fig. 1 Body mass index before and after surgery. The body mass
index before 1, 2, and 5 years after DS. The bold lines represent mean
values. The dotted line represents the upper limit for normal BMI
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Our findings are in accordance with the studies byKarlsson
et al. [9] and Kolotkin et al. [15] who also found very large
long-term improvements in HRQL after bariatric surgery
(banding, vertical-banded gastroplasty, and gastric bypass),
despite the small early declines in HRQL. Other studies with
a range of surgical procedure have found similar findings
[12–14, 20, 34].
The Swedish Obese Subjects (SOS) intervention study [9]
demonstrated that long-lasting weight reduction in the severe-
ly obese has a general long-standing positive outcome on
HRQL. The SOS study found that the pattern of change in
HRQL scores corresponded with weight loss, weight regain,
and weight stability. Kolotkin et al. [15] found that PCS and
the Impact of Weight on Quality of Life-Lite questionnaire
(IWQOL-Lite) [35] correlated strongly with weight loss,
while the mental aspects of HRQL, as assessed by MCS, did
not. In our study, there were no significant correlations be-
tween weight loss and change in HRQL, except for the SF-36
subscore physical functioning. Thus, this score is probably
especially sensitive for weight changes. It might be that in our
study, many patients had a weight loss that exceeded a thresh-
old above which little further improvement in nonphysical
HRQL could be observed. Although HRQL has been
measured differently in several studies, the consistency
of findings across studies suggests that there is a posi-
tive relationship between weight loss and improvement
of HRQL [9, 15, 36].
Our comparisons of HRQL by the 5-year follow-up with
the normative Norwegian population, both unadjusted and
adjusted for BMI, revealed interesting results. The PCS score
was significantly different from the normative population
adjusted for age and gender, but the difference disappeared
whenwe adjusted for BMI. Thus, the patients in this study had
the comparable PCS as persons with similar BMI in the
general population. The MCS score tells a different story as
it was different from the norm population adjusted for age and
gender and also after adjustment for BMI. Thus, the lower
MCSwas unrelated to the BMI.We can only speculate on this,
but the HADS scores may shed some light on this issue. The
HADSD score, not the HADSA score, showed large and
sustained improvements after surgery, which is in agreement
with findings in other studies [37–39]. The patients may face
challenges related to self-concept, social relations, and skill
acquisition [40], and some of them may regain some of their
weight [38]. How patients cope with these matters might have
an influence on anxiety in particular.
Two of the strengths of the present study are the long-
term follow-up for 5 years and a very high response rate
(92 %). Another strength of this study is our use of well-
validated HRQL instruments that allowed us to compare the
results with population norms. However, there are also several
limitations to our study, and one is the lack of a control group.
It could be held that some of the change in HRQL could partly
be due to other factors than surgery. For ethical reason, one
cannot randomize patients with morbid obesity in clinical
studies. With this background, it is held that prospective
Fig. 2 SF-36 summary scores before and after duodenal switch. PCS and
MCS are presented as mean and 95 % CI. The dotted line represents the
mean score for the normal population, adjusted for age, gender and BMI
Fig. 3 HADS scores before and after duodenal switch. Anxiety and
depression scores are presented as means and 95 %CIs. The dotted line
represents the mean score for the normal population, adjusted for age,
gender and BMI
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cohort studies with clear treatment goals, careful monitoring
of the individuals, and long follow-up (at least 5 years) is a
design well suited for evaluating treatment of morbid obesity
[41]. We are well aware that an obesity-specific HRQL ques-
tionnaire would have been very useful in this study as well,
such as the IWQOL-Lite, because the items deal with con-
cerns that are specific to obese persons. Finally, question-
naires cannot describe the patient’s life situation in deeper
and broader sense. That requires other methods as, for exam-
ple, qualitative interviews.
Conclusions
Overall, this study shows that BPDDS was associated with
great improvements in HRQL 5 years after BPDDS. The PCS
was comparable to the population norm, whileMCSwas lower.
This may be due the sustained reduction in HADSD but not in
HADSA. Further long-term studies should be performed to
confirm these findings and other outcomes after BPDDS.
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